Physicians Formula predicts lower sales

By Simon Pitman

- Last updated on GMT

Masstige skin care provider Physicians Formula says that soft
market conditions within the segment have led it to lower its
forecast for the forthcoming quarter and full year, prompting fears
for other big name prestige player.

The company said that in reaction to softer spending in the segment in the US, in the past month drug stores have lowered the number of product re-orders, which is in turn affecting sales.

The company said that second quarter sales came in at $22.1m, above the company's own expectations, but down by more than 4 percent compared to the same period last year.

This is in contrast to a strong first quarter, which meant that sales for the first six months were up 13.8 per cent to reach $57.8m.

The company said it was expecting full year sales of $110m to $115m, but has reduced that outlook to $107m to $111m, and also said that it expected share dividends to be lower as a result.

Third quarter sales are now predicted at between $18.5 million and $20.5 million, a result that it likely to lead to a small dividend loss for shareholder and one that was below analyst expectations of $22m.

Mulling the lower orders from drug stores, Ingrid Jackel, company chief executive officer, pointed to the fact that data from market research provider Nielsen points to the fact that during the four weeks up to July 14 drug stores sales grew by 15 per cent, suggesting that as a whole, the segment was reasonably buoyant.

In turn, Jackel stated her belief that the change in the re-stocking procedures for drug retailers has been a significant cause of the lower sales, suggesting that this might be contributing to the problem for prestige personal care makers as a whole.

However, Jackel did concede that the Nielsen data shows the masstige market "is softening slightly, with sales for the premium segment as a whole down 2 percent for the four week period up to July 14, according to the Nielsen figures".

Created in 1937, the Physicians Formula name represent a number of brand names that concentrate on the treatment of skin imperfections, with the products being sold in leading retailers all over the US, including CVS, Target and Wal-Mart.

As well as Physicians Formula, the masstige skin care market also includes names such as Almay, L'Oreal, Max Factor, Revlon and Neutrogena - companies that will all be closely analyzing their rivals results.

Related topics Business & financial Skin care

Related products

show more

Discover Peptan for Beauty & Diverse Skins

Discover Peptan for Beauty & Diverse Skins

Content provided by Rousselot | 05-Sep-2024 | Product Brochure

As beauty from within solutions soar in popularity, manufacturers need to be able to serve everyone, no matter their ethnicity or skin type.

FucoSkin®: Ocean-Inspired Sustainable Beauty

FucoSkin®: Ocean-Inspired Sustainable Beauty

Content provided by Hi-Q Marine Biotech International Ltd | 28-Aug-2024 | White Paper

FucoSkin® is a fucoidan-rich extract derived from the brown seaweed Laminaria Japonica, known for its excellent anti-aging and photoprotective benefits....

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Related suppliers

Follow us

Products

View more

Webinars

Podcast